Evidence map›Paper›PMID 21873835›Full record

Trial reportThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2011

Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.

Tonita E Wroolie, Heather A Kenna, Katherine E Williams, Bevin N Powers, Megan Holcomb, Anna Khaylis, Natalie L Rasgon

Open access · greenAbstract readClinical TrialComparative Study
In one paragraph

Trial report in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. One size does not fit all: how type of menopause and hormone therapy matters for brain health.The British journal of psychiatry : the journal of mental science · 2025
    Review
  7. Early midlife ovarian removal is associated with lower posterior hippocampal function.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Sex Differences in Dementia.Current topics in behavioral neurosciences · 2023
    Review
  14. The X factor in neurodegeneration.The Journal of experimental medicine · 2022
    Article
  15. Article
  16. Precision hormone therapy: identification of positive responders.Climacteric : the journal of the International Menopause Society · 2021
    Review
  17. Menopause, hormone therapy and cognition: maximizing translation from preclinical research.Climacteric : the journal of the International Menopause Society · 2021
    Review
  18. Article
  19. Article
  20. SeXX Matters in Multiple Sclerosis.Frontiers in neurology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tonita E WroolieStanford Center for Neuroscience in Women's Health, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94303-5723, USA.
Heather A Kenna
Katherine E Williams
Bevin N Powers
Megan Holcomb
Anna Khaylis
Natalie L Rasgon
Stanford University · US

Funding

XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGYM01RR000070 · NCRR · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 1985 to 2008
$32.4M
Estrogen Use in Protection from Cognitive DeclineR01AG022008 · NIA · STANFORD UNIVERSITY · PI RASGON, NATALIE L · 2003 to 2010
$2.5M
NCRR NIH HHS M01 RR000070NCRR NIH HHS M01 RR-00070NIA NIH HHS R01 AG022008NIA NIH HHS R01 AG22008
6 · The paper itself

Abstract

objectiveMuch controversy exists and many questions remain unanswered about the effects of hormone therapy (HT) on cognition in postmenopausal women. There is growing evidence suggesting that HT compounds containing conjugated equine estrogen (CEE) have negative effects on cognition whereas 17β-estradiol (17β-E) either has positive or neutral effects. The present study sought to further examine this issue in a sample of postmenopausal women with risk factors for Alzheimer's disease (AD).

designCross-sectional neuropsychological evaluation.

settingAcademic research clinic.

participants68 healthy postmenopausal women (aged 49-68) receiving either 17β-E or CEE for at least one year with increased risk for AD. MEASUREMENTS: Neuropsychological test battery of the cognitive domains of attention/working memory/processing speed, verbal memory, visual memory, and executive functioning.

resultsMultivariate analyses of variance (MANOVA) showed significantly better verbal memory performance in women receiving 17β-E compared to women receiving CEE regardless of age, IQ, years of education, risk factors for AD (including APOE-ε4 carriership), duration of endogenous and exogenous estrogen exposure, concurrent progesterone use, or natural versus surgical menopause status.

conclusionsVerbal memory performance was better in postmenopausal women receiving 17β-E compared to CEE in a sample population of women with risk factors for AD. Genetic risk for AD as well as other confounds did not affect this finding. The results suggest a differential effect of HT type on verbal memory, with 17β-E being a preferential compound. Further evaluation of HT types, regimens and duration of use on cognitive performance in postmenopausal women in a controlled longitudinal design is warranted.

Indexed as

AgedAlzheimer DiseaseCross-Sectional StudiesEstradiolEstrogen Replacement TherapyEstrogens, Conjugated (USP)Executive FunctionFemaleHumansMemoryMiddle AgedNeuropsychological TestsPostmenopausePsychomotor PerformanceRisk FactorsVerbal BehaviorEstradiolEstrogens, Conjugated (USP)

Identifiers

PMID21873835
PMCPMC3164805
OpenAlexW2106075119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.